PNPLA3基因多态性降低非酒精性脂肪性肝病患者的糖尿病易感性
本研究利用活检确诊的非酒精性脂肪性肝病(NAFLD)队列(n=706)和纵向观察队列(n=4998),探讨PNPLA3 rs738409基因型与糖尿病(DM)风险的关系。结果显示,在NAFLD患者中,G等位基因独立关联较低DM患病率(NAFL OR 0.66,NASH OR 0.59)和较低 incident DM 风险(HR 0.65);而无NAFLD的G等位基因携带者DM风险反而升高(OR 2.44)。
要点
- PNPLA3 rs738409 G等位基因在NAFLD患者中与较低DM患病率和发病风险相关。
- 无NAFLD者携带G等位基因反而与更高的DM风险相关。
- 遗传性NAFLD可能具有较低代谢风险,解释基因型与DM关联的矛盾。
核心结论
- PNPLA3 rs738409基因型与DM风险的关联在有无NAFLD者中方向相反,NAFLD患者中G等位基因降低DM风险。
研究设计与样本
- 研究采用活检确诊NAFLD的Boramae队列(n=706)评估基因型与DM患病率关联,并在纵向GENIE队列(n=4998)中分析incident DM风险。
主要发现
- 在Boramae队列NAFLD患者中,G等位基因独立关联较低DM患病率:NAFL OR 0.66(95%CI 0.46-0.97),NASH OR 0.59(95%CI 0.38-0.92)。
- 在GENIE队列NAFLD患者中,中位随访60个月,G等位基因关联较低incident DM风险(HR 0.65,95%CI 0.45-0.93)。
- 在Boramae队列无NAFLD者中,G等位基因携带者DM风险更高(OR 2.44,95%CI 1.00-5.95)。
临床怎么用
- 对NAFLD患者进行PNPLA3 rs738409基因分型可能有助于糖尿病风险分层。
- 无NAFLD的G等位基因携带者应关注糖尿病风险,而非低估。
局限性
- 研究基于特定队列,结果需外部验证;未报告其他潜在混杂因素控制细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: We investigated the association between the patatin-like phospholipase domain-containing-3 (PNPLA3) rs738409 genotype and the risk of diabetes mellitus (DM) using a biopsy-confirmed nonalcoholic fatty liver disease (NAFLD) cohort and a longitudinal observational cohort. METHODS: Associations between genotypes and the prevalence of DM were evaluated with stratification according to the histological severity of NAFLD in the Boramae cohort (n = 706). A longitudinal cohort consisting of nondiabetic individuals with ≥2 health checkups was then selected to investigate the risk of incident DM according to the genotype (the GENIE cohort; n = 4998). RESULTS: Among subjects with NAFLD in the Boramae cohort, the G allele was independently associated with a lower prevalence of DM in both NAFL (odds ratio [OR] per 1 allele, 0.66; 95% confidence interval [CI], 0.46-0.97) and nonalcoholic steatohepatitis (OR per 1 allele, 0.59; 95% CI, 0.38-0.92). This result was replicated in the longitudinal GENIE cohort. The G allele was associated with a lower risk of incident DM during the median follow-up of 60 months in subjects with NAFLD (hazard ratio, 0.65; 95% CI, 0.45-0.93). In contrast, G allele carriers without NAFLD showed higher odds for DM in the context of the Boramae cohort (OR, 2.44; 95% CI, 1.00-5.95). CONCLUSIONS: These findings clarify conflicting results regarding the association between the PNPLA3 rs738409 genotype and the risk of DM, demonstrating a clear difference between subjects with and without NAFLD; this difference might be explained by the low metabolic risk in genetic NAFLD.
引用
- Moon S, Chung GE, Joo SK, et al. A PNPLA3 Polymorphism Confers Lower Susceptibility to Incident Diabetes Mellitus in Subjects With Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2021. PMID: 33905771. doi:10.1016/j.cgh.2021.04.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。